Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2025
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 11, 2023
STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Journal: Journal of the National Cancer Institute
Published: November 15, 2018
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma.
Journal: Translational cancer research
Published: October 05, 2018
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017).
Journal: Oncoimmunology
Published: July 30, 2018
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 04, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 29, 2017
Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.
Journal: Journal of neuroimmunology
Published: September 19, 2017
Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.
Journal: Oncoimmunology
Published: June 26, 2017
The Boosting Potential of Bacteria in Cancer Immunotherapy.
Journal: Trends in molecular medicine
Published: April 28, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2017
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Journal: Brain, behavior, and immunity
Published: October 17, 2016
Last Updated: 09/26/2026